Chronological Index of : Management Tracks

• 23andMe management update

  23andMe Inc., Mountain View, Calif. Business: Diagnostic Hired: Andy Page, a director, as president, a newly created position, formerly president of Gilt Groupe Holdings Inc.

  Published on 6/17/2013

• Affymax board of directors update

  Affymax Inc. (OTCQB:AFFY), Palo Alto, Calif. Business: Hematology Appointed: John Orwin as chairman; he succeeds Hollings Renton, who remains a director

  Published on 6/17/2013

• Affymax management update

  Affymax Inc. (OTCQB:AFFY), Palo Alto, Calif. Business: Hematology Hired: CEO of The Brenner Group, Rich Brenner as CEO and a director; he succeeds John Orwin, who becomes chairman; Weston Rose, an SVP at The Brenner …

  Published on 6/17/2013

• Allenex management update

  Allenex AB (SSE:ALNX), Stockholm, Sweden Business: Transplant Resigned: Michael Petruny as general manager of Allenex's Olerup Inc. subsidiary; he will be replaced by Anders Karlsson, CEO of Allenex and Olerup, until a …

  Published on 6/17/2013

• Anthera management update

  Anthera Pharmaceuticals Inc. (NASDAQ:ANTH), Hayward, Calif. Business: Autoimmune, Cardiovascular Departing: Christopher Lowe as CBO and CFO, effective June 30 Transitioned: May Liu to SVP of finance and administration …

  Published on 6/17/2013

• Autifony board of directors update

  Autifony Therapeutics Ltd., London, U.K. Business: Other Appointed: Elaine Jones, executive director of venture capital at Pfizer Venture Investments

  Published on 6/17/2013

• Cubist management update

  Cubist Pharmaceuticals Inc. (NASDAQ:CBST), Lexington, Mass. Business: Infectious Hired: Lorianne Masuoka as CMO and SVP of clinical development and medical affairs

  Published on 6/17/2013

• Dezima management update

  Dezima Pharma B.V., Naarden, the Netherlands Business: Cardiovascular Hired: Rob de Ree as CEO, formerly CEO of Bmeye B.V., which Edwards Lifesciences Corp. acquired; he replaces Interim CEO Sander van Deventer

  Published on 6/17/2013

• GrayBug management update

  GrayBug LLC, Baltimore, Md. Business: Drug delivery, Ophthalmic Hired: Gerald Cagle as a senior advisor and head of business development, formerly SVP and CSO of Alcon Inc., which Novartis AG acquired

  Published on 6/17/2013

• Histogenics management update

  Histogenics Corp., Waltham, Mass. Business: Musculoskeletal Hired: Peter Greenleaf as CEO, formerly president of AstraZeneca plc's MedImmune LLC unit; he replaces Patrick O'Donnell

  Published on 6/17/2013

• miRagen management update

  miRagen Therapeutics Inc., Boulder, Colo. Business: Cardiovascular Hired: Christopher Morl as CBO

  Published on 6/17/2013

• Polyphor board of directors update

  Polyphor Ltd., Allschwil, Switzerland Business: Hematology, Cancer, Infectious Appointed: Jerry Karabelas as chairman

  Published on 6/17/2013

• Regulus board of directors update

  Regulus Therapeutics Inc. (NASDAQ:RGLS), San Diego, Calif. Business: Infectious, Cancer, Cardiovascular Appointed: Stelios Papadopoulos as chairman; he replaces John Maraganore, who remains a director

  Published on 6/17/2013

• StemCells management update

  StemCells Inc. (NASDAQ:STEM), Newark, Calif. Business: Gene/Cell therapy, Neurology Hired: Eliseo Salinas as EVP and head of R&D, formerly EVP, head of development and CMO of Elan Corp. plc; he replaces Ann Tsukamoto, …

  Published on 6/17/2013

• Summit management update

  Summit Corp. plc (LSE:SUMM), Abingdon, U.K. Business: Musculoskeletal, Endocrine/Metabolic, Infectious Hired: David Roblin as CMO, while remaining CMO of Creabilis S.A.

  Published on 6/17/2013

• Agendia management update

  Agendia B.V., Amsterdam, the Netherlands Business: Diagnostic, Microarrays Hired: Peter Schineller as chief commercial officer, a newly created position, formerly SVP and chief commercial officer of Alexza …

  Published on 6/10/2013

• Akebia board of directors update

  Akebia Therapeutics Inc., Cincinnati, Ohio Business: Hematology, Cardiovascular Appointed: Kim Dueholm, partner at Novo A/S; Giovanni Ferrara, venture partner at Novartis Venture Fund; Jack Nielsen, partner at Novo; …

  Published on 6/10/2013

• Atossa Genetics management update

  Atossa Genetics Inc. (NASDAQ:ATOS), Seattle, Wash. Business: Diagnostic Hired: Peter Carbonaro as SVP of operations, a newly created position, formerly VP of operations at Ondine Biomedical Inc.

  Published on 6/10/2013

• Avaxia Biologics board of directors update

  Avaxia Biologics Inc., Lexington, Mass. Business: Antibodies, Endocrine/Metabolic, Autoimmune Appointed: David Donabedian, managing director at AbbVie Biotech Ventures Inc.

  Published on 6/10/2013

• Coronado Biosciences management update

  Coronado Biosciences Inc. (NASDAQ:CNDO), Burlington, Mass. Business: Autoimmune, Cancer Hired: George Avgerinos as SVP of biologics operations, formerly VP of Humira adalimumab manufacturing sciences and external …

  Published on 6/10/2013

• DBV management update

  DBV Technologies (Euronext:DBV), Bagneux, France Business: Inflammation, Diagnostic Hired: Veronique Foutel as chief strategic marketing officer

  Published on 6/10/2013

• Easton Pharmaceuticals management update

  Easton Pharmaceuticals Inc. (Pink:EAPH), Toronto, Ontario Business: Drug delivery, Dermatology Hired: Neil Mellor as a senior consultant and COO

  Published on 6/10/2013

• GenMark Diagnostics management update

  GenMark Diagnostics Inc. (NASDAQ:GNMK), Carlsbad, Calif. Business: Diagnostic Transitioned: Jon Kayyem to SVP of R&D while remaining CSO; he replaces Jorge Garces, who resigned

  Published on 6/10/2013

• Innovus management update

  Innovus Pharmaceuticals Inc. (OTCBB:INNV), La Jolla, Calif. Business: Dermatology, Cancer Hired: Morgan Brown as EVP and CFO

  Published on 6/10/2013

• Kite Pharma management update

  Kite Pharma Inc., Los Angeles, Calif. Business: Cancer Hired: Keith Nolop as CMO, formerly SVP of development and CMO of Plexxikon Inc., which Daiichi Sankyo Co. Ltd. acquired

  Published on 6/10/2013